Regeneron initiated a precautionary voluntary recall because of incidents of syringe barrel breakage that can occur upon receipt, preparation, or dose delivery.
Regeneron has not received reports of associated adverse events.
This appears to have affected the six lots listed below. For further information and a full-size copy of the chart, read the Regeneron recall letter (PDF).
If you examine your inventory and have products with a listed lot number, contact recallreturns@regeneron.com for a Return Goods Authorization, retrieval kit, and UPS return label.
The Academy will continue to monitor how this will affect retina and other ophthalmic practices and will update members if there are new developments.
For further questions, contact quality@aao.org.
